Total planned funding: $388,268,429
Clear active filters
Namibia
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Namibia | $388,268,429 |
Organizational Types
| NGO | $112,623,871 |
| Private Contractor | $82,062,145 |
| Host Country Government Agency | $65,753,932 |
| Own Agency | $43,124,151 |
| University | $31,159,836 |
| Unknown | $25,419,855 |
| Parastatal | $9,983,041 |
| Other USG Agency | $7,432,105 |
| Multi-lateral Agency | $3,966,437 |
| FBO | $3,410,045 |
| Implementing Agency | $3,333,011 |
Program Areas
| Treatment | $98,389,715 |
| Prevention | $81,290,553 |
| Care | $79,545,792 |
| Governance and Systems | $59,726,979 |
| Management and Operations | $35,719,201 |
| Testing | $33,596,189 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $77,617,776 |
| HVMS: Management and Operations | $35,719,201 |
| HVCT: Testing: HIV Testing and Counseling | $33,596,189 |
| HKID: Care: Orphans and Vulnerable Children | $31,100,064 |
| HBHC: Care: Adult Care and Support | $30,319,195 |
| OHSS: Health Systems Strengthening | $29,061,510 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $27,272,829 |
| HVSI: Strategic Information | $23,303,516 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $21,387,926 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $17,475,295 |
| HTXD: Treatment: ARV Drugs | $16,342,019 |
| HVTB: Care: TB/HIV | $11,786,000 |
| HLAB: Laboratory Infrastructure | $7,361,953 |
| HMBL: Biomedical Prevention: Blood Safety | $6,706,235 |
| PDCS: Care: Pediatric Care and Support | $6,340,533 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $5,487,805 |
| PDTX: Treatment: Pediatric Treatment | $4,429,920 |
| HMIN: Biomedical Prevention: Injection Safety | $2,960,463 |
Top Partner Programs
Potentia Namibia:
$41,500,825
Countries/Regions
Not Available:
$24,452,480
Countries/Regions
USG Aggregated Agencies:
$24,009,766
Countries/Regions